pivekimab sunirine
immunogen
['cadenza', 'pivekimab', 'immunogen ', '$imgn']
news; $imgn immunogen presents updated findings from cadenza trial of pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm at eha 2023 congress #stockmarket #news $cfrx $sien $brze via 